Patent ID: 7842711

Claim:
A method of treating malaria or inhibiting Plasmodium falciparum parasite in a patient in need thereof, which comprises administering to said patient an effective amount of a compound corresponding to general formula (I): in which: R 1 represents a heteroaromatic group optionally substituted with one or two substituents chosen, independently of one another, from halogen atoms and heteroaromatic, C 1-6 alkyl, —OH, —NH 2 , —NHR 2 , —NHCOR 2 , —COOR 2 , —CONH 2 , —CONHR 2 and —CH 2 XR 2 groups, where X is chosen from O, NH and S; Ar represents a heteroaromatic group optionally substituted with one or two substituents chosen, independently of one another, from halogen atoms and C 1-6 alkyl, C 1-6 thioalkyl, C 1-6 alkoxy, —CH 2 OH, phenoxy, morpholinyl, —CH 2 -morpholinyl, —NH 2 , —NHR 2 , —NR 2 R 3 , —NHSO 2 R 2 , —CN, —SO 2 R 2 , —SO 2 NH 2 , —SO 2 NHR 2 , —COOH, —COOR 2 , —CONH 2 , —CONHNH 2 , —CONHR 2 , —CH 2 NHR 2 and —CH 2 NR 2 R 3 groups; R 2 and R 3 , which may be identical to or different from one another, represent a C 1-6 alkyl group optionally substituted with a —CONH 2 group, with a phenyl group or with a heteroaromatic group; or else R 2 and R 3 , which may be identical to or different from one another, represent a phenyl group or a heteroaromatic group; and n is equal to 0, 1, 2 or 3, or a pharmaceutically acceptable salt, hydrate or solvate thereof.